I live in London <a href="http://barlens.com.au/medartclinicsnet-72f7.pdf#solve">loophomemedical.com</a>  With recent setbacks for Lilly's experimental treatments forcancer and Alzheimer's disease as well as the impending genericcompetition, investors remain cautious on the company. Itsshares have risen 6.1 percent this year, lagging a 17 percentadvance for the Arca Pharmaceutical Index of large U.S.and European drugmakers.